March 23, 2026 a 08:00 am
ABBV: Fundamental Ratio Analysis - AbbVie Inc.
AbbVie Inc. presents a solid opportunity in the pharmaceuticals sector, driven by a robust portfolio of products treating various serious health conditions. However, the company faces competition and regulatory challenges that may impact growth. Investors should weigh these factors when considering an investment in ABBV.
Fundamental Rating
The fundamental analysis shows mixed results for AbbVie Inc., with a moderate overall score reflecting certain strengths and weaknesses in key financial metrics.
| Category | Score | |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 1 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 1 |
Historical Rating
The historical data indicates a stable performance with consistent scores across the board.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-03-20 | 2 | 4 | 1 | 4 | 1 | 1 | 1 |
| N/A | 0 | 4 | 1 | 4 | 1 | 1 | 1 |
Analyst Price Targets
Analysts have set varied price targets for ABBV, indicating potential upside but also significant differences in opinion.
| High | Low | Median | Consensus |
|---|---|---|---|
| 299 | 223 | 258 | 256.15 |
Analyst Sentiment
The analyst sentiment is largely positive, with a strong majority recommending buying the stock.
| Recommendation | Count | |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 26 | |
| Hold | 12 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
AbbVie Inc. holds a strong position in the pharmaceuticals market with a diverse product portfolio. While the fundamental analysis shows areas for improvement, the overall analyst sentiment remains positive. Investors should consider the potential risks of market competition and regulatory changes before investing. The stock's mixed analyst price targets highlight its attractiveness and the accompanying uncertainties in the market.